Table 1.
Correlations between tumor infiltrating ILC3s and clinicopathological factors of colon cancer.
| Factors | N | ILC3s# | P-value |
|---|---|---|---|
| Age | |||
| < 65 | 23 | 0.48 (0.38, 0.75) | 0.29 |
| ≥ 65 | 35 | 0.62 (0.37, 0.98) | |
| Sex | |||
| Male | 32 | 0.50 (0.29, 0.79) | 0.26 |
| Female | 26 | 0.64 (0.41, 0.80) | |
| Region | |||
| Ascending/Transverse | 40 | 0.62 (0.38, 0.92) | 0.34 |
| Descending/Sigmoid | 18 | 0.60 (0.30, 0.74) | |
| T stage | |||
| T2/T3 | 37 | 0.56 (0.40, 0.87) | 0.54 |
| T4 | 21 | 0.51 (0.33, 0.75) | |
| N stage | |||
| N0/N1 | 26 | 0.51 (0.29, 0.79) | 0.38 |
| N3/N4 | 32 | 0.67 (0.43, 0.84) | |
| M stage | |||
| M0 | 52 | 0.59 (0.38, 0.87) | 0.20 |
| M1 | 6 | 0.47 (0.20, 0.65) | |
| AJCC stage | 0.04 | ||
| I /II | 24 | 0.70 (0.43, 1.27) | |
| III/IV | 34 | 0.48 (0.31, 0.71) | |
#The percentage of ILC3s in tumor versus distal tissue.